*Aurinia Pharmaceuticals Inc.

Changing the course of autoimmune disease

Inspired by patients. Driven to make an impact.

Latest News

March 6, 2023 • 4:00pm EST

Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read Press Release View All News

February 28, 2023 • 6:00am EST

Aurinia Reports Fourth Quarter and Full Year 2022 Financial Results and Company Updates

Read Press Release View All News

February 24, 2023 • 6:00am EST

Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference

Read Press Release View All News